FDA nominee pitches AI application review
WASHINGTON WATCH
'There's a number of opportunities with AI right now that we have that we've never had before,' Dr. Marty Makary, President Donald Trump's nominee to lead the Food and Drug Administration, told a panel of lawmakers he hopes will confirm him.
In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, Labor and Pensions Committee. He was quick to add that AI would assist reviewers, not replace them.
He also said AI could be used to aid with data monitoring after a drug has been approved. 'So that we don't learn five years after Vioxx was approved that 38,000 Americans died from it,' he said.
Vioxx was a pain killer that was removed from the market after it was found to raise the risk of heart attack and stroke. Dr. David Graham, former associate director in the FDA's Office of Drug Safety, estimated that between 88,000 and 139,000 Americans had heart attacks and strokes as a result of taking the drug, some of which were fatal.
Open questions: But the Johns Hopkins surgeon also said the FDA could potentially share data with drug developers that might help them 'train machine learning models, to help design AI systems that can predict toxicities, adverse events, and even cures for some conditions.'
Drug developers are also thinking about how AI can help prevent the advancements of drugs that could ultimately get pulled. It's unclear how the FDA could play a role in that. One question is: What data could FDA provide that wouldn't be proprietary to the companies?
Background: Former Commissioner Robert Califf also talked about using AI internally at the FDA, particularly for compliance monitoring. But those plans were dashed after Trump won the election and Califf left the FDA.
So far, the Trump administration has unwound much of the Department of Health and Human Services' work to lay a foundation to use and regulate AI. Recently, it took down a public-facing document laying out HHS's AI strategy.
WELCOME TO FUTURE PULSE
This is where we explore the ideas and innovators shaping health care.
Butterflies are vanishing from America, with potentially dire impacts on pollination that sustains plants and crops, the Washington Post reports.
Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Ruth Reader at rreader@politico.com, or Erin Schumaker at eschumaker@politico.com.
Are you a current or former federal worker who wants to share a tip securely? Message us on Signal: CarmenP.82, DanielP.100, RuthReader.02 or ErinSchumaker.01.
WORLD VIEW
America's sudden freezing and subsequent termination of most foreign aid funding is crippling tuberculosis services in countries with the highest number of cases and risks reversing decades of progress against one of the world's top infectious disease killers, the World Health Organization warned Wednesday.
To date, thousands of health workers have been suspended and face layoffs, and that has impacted essential health services and drug supply chains. Laboratory testing services are 'severely disrupted,' the WHO said, due to delays in sample transportation and shortages of essential laboratory materials, halting efforts to diagnose more people with the disease.
'Community engagement efforts — including active case finding, screening, and contact tracing — are deteriorating, reducing early TB detection and increasing transmission risks,' the WHO added.
The Trump administration has terminated multiyear grants, contracts or agreements on tuberculosis worth at least $820 million, according to a POLITICO analysis of a document it obtained listing all terminations. The figure doesn't include programs focusing on both tuberculosis and HIV/AIDS or on tuberculosis and other conditions.
Research on tuberculosis has also been impacted, since the U.S. Agency for International Development, which the Trump administration has gutted, has halted all the clinical trials it was funding, the WHO said.
USAID was among the top three research funders in the world for tuberculosis, according to the WHO.
Why it matters: Tuberculosis has consistently been the world's top infectious disease killer, besides the years where Covid-19 took its spot.
More than 10 million people globally fell ill from tuberculosis in 2023, the latest year for which data is available. Around 1.2 million people died of tuberculosis that year.
Just over two dozen countries account for most of the world's tuberculosis cases — including India, Indonesia and the Philippines — and 18 of them depend significantly on U.S. funding.
America has provided between $200 to and $250 million yearly in bilateral funding for tuberculosis. This funding represented about one quarter of the total amount of international donor funding for tuberculosis, the WHO said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
22 minutes ago
- New York Times
With Flu Shot Vote, Kennedy's Vaccine Skepticism Comes Full Circle
A decade before he became President Trump's health secretary, the environmental lawyer Robert F. Kennedy Jr. appeared on a talk show hosted by Dr. Mehmet Oz to promote his latest book, 'Thimerosal: Let the Science Speak.' The book, published in 2014, explored an obscure mercury-based preservative, thimerosal, that was removed from most vaccines, but not flu vaccines, more than two decades ago. Dr. Oz noted that the Centers for Disease Control and Prevention had deemed the vaccines that still contained thimerosal 'safe and effective' and said they did 'not present a public health risk.' Mr. Kennedy did not buy it. 'We found 500 peer-reviewed studies,' he insisted. 'Virtually every one of them said that thimerosal is a potent neurotoxin that should not be in vaccines.' On Thursday, the new members of the C.D.C.'s Advisory Committee on Immunization Practices, hand-selected by Mr. Kennedy after he fired all 17 members of the previous panel, decided it would longer recommend annual flu shots that contain it. Thimerosal's appearance on the committee's agenda in the first place shocked public health leaders, who have long considered the matter settled. But it was not a surprise to people who have followed Mr. Kennedy closely. Thimerosal started Mr. Kennedy down a path of questioning vaccine safety, and Thursday's vote was the culmination of a long personal journey. It offers a window into how, as secretary, he is pursuing his own passions and installing old allies in positions of influence. Want all of The Times? Subscribe.
Fox News
27 minutes ago
- Fox News
Disposable vapes more toxic and carcinogenic than cigarettes, study shows
Illegal disposable e-cigarettes, also known as vapes, may present a greater danger than traditional cigarettes, according to a study from the University of California (UC) Davis. The research, published in the journal ACS Central Science, found that hazardous levels of several toxic heavy metals in illegal vapes could present a high cancer risk. Researchers used a special instrument to test the puffs from three popular vape brands — ELF Bar, Flum Pebble and Esco — that are not FDA-authorized for use in the U.S., but are widely sold by retailers. Three heavy metals — lead, nickel and antimony — were detected in all heavily flavored and lightly flavored devices that were tested. These metals are classified as carcinogens, potentially leading to various types of cancers, such as skin, lung and kidney, according to the National Institutes of Health (NIH). All vapors exceeded the cancer risk limits for nickel, which has been linked to cardiovascular disease, asthma, lung fibrosis and respiratory tract cancer, per NIH. Brett Poulin, senior study author and assistant professor at the UC Davis Department of Environmental Toxicology, told Fox News Digital that he was shocked at the levels of toxic metals. "When I analyzed the first samples, the lead concentrations were so high that I genuinely thought the instrument was broken," he said. "The levels far exceeded anything in our past data, or even the published literature." One of the brands tested exposes users to as much lead as smoking 19 packs of cigarettes, the researchers discovered. Additionally, most of the disposable e-cigarettes tested in the study were found to contain greater levels of metals and metalloids than older refillable vapes. At one point, Poulin said, he physically opened a device and discovered that it was using leaded copper alloys, which are metals made primarily of copper with small amounts of lead. "These materials leached dangerous levels of lead into the e-liquid, even without the device being used," Poulin told Fox News Digital. "It remains unclear whether this was an intentional design choice, a cost-cutting measure or a manufacturing oversight." "This neurotoxin poses serious health risks, particularly to children and adolescents." There is no known safe level of lead exposure, according to Poulin. "This neurotoxin poses serious health risks, particularly to children and adolescents, who are especially vulnerable." Daniel Sterman, M.D., director of the Pulmonary Oncology Program at the NYU Langone Perlmutter Cancer Center, told Fox News Digital that the study "clearly" demonstrates high concentrations of metal. "There are several health risks of vaping that we enumerate for our patients and their family members, [such as] risks of various lung diseases, including asthma, COPD and lung cancer," said Sterman, who was not involved in the study. The doctor noted that while it is challenging to establish a direct link of causation between disposable vapes and cancer, he does see cancer patients who use the devices. "Disposable vapes should be highly regulated by local, state and federal agencies, and restricted to those individuals 21 years or older," Sterman recommends. The doctor also called for the packaging on disposable vapes to clearly outline the many health risks, "particularly to teenagers and young adults." One of the primary limitations of the study was that only three disposable e-cigarette brands were tested out of the hundreds currently on the market. There are distinct differences in the metal leaching and profiles across all three brands, Poulin shared. "We still know very little about the metal content in the vast majority of untested disposable e-cigarette products," he said. "This gap in knowledge poses a significant public health concern, especially given the popularity of these devices." A spokesperson for the China-based brand, ELFBAR, told Fox News Digital that they refute the results of the study, claiming that they stopped shipments in May 2023. Due to ongoing trademark litigation, they are unable to market or sell products in the U.S., the company stated. "This market void has led to a surge in counterfeits, imitations and illicit variations misusing our brand name," the spokesperson said. "As such, we have every reason to believe the devices tested in this study are not genuine and were not manufactured by ELFBAR." The spokesperson acknowledged that smoking remains the leading cause of preventable death and disease worldwide, noting that the recent study "continues to undermine public understanding of smoking cessation." The other two brands tested in the study did not respond to requests for comment. "Disposable vapes should be highly regulated by local, state and federal agencies and restricted to those individuals 21 years or older." Electronic cigarette use among adults increased from 4.5% in 2019 to 6.5% in 2023, according to the U.S. Centers for Disease Control and Prevention (CDC). Men are more likely to vape than women, while 15.5% of young adults between the ages of 21 and 24 reported using e-cigarettes, the above source states. For more Health articles, visit The UC Davis study received support from the University of California Tobacco-Related Disease Research Program Grant and the California Agricultural Experiment Station.
Forbes
an hour ago
- Forbes
The Hi-Tech Products To Improve Wellness When You Travel
One of the big travel trends for 2025 is the advancement of technology and AI to facilitate the way we travel. An Amadeus study shows that 46% of travel companies feel it is a top priority for 2025. The report, Navigating the Future: How Generative Artificial Intelligence is Transforming the Travel Industry , surveyed more than 300 experts from across the sector about the growing importance of generative AI within the travel sector. But, in addition to simplifying bookings, check-in procedures, and itinerary planning, technology is also leading the way in enhancing wellness for travelers away from home. For instance, at Hyatt hotels, reports the BBC, an AI-powered bed can monitor your heart rate, movement and blood pressure to offer more comfort and a better night's sleep. This also feeds into the 'burgeoning prioritization of wellness' among Millennials and Gen-Zs, with the latest Future of Wellness report by McKinsey revealing: 'Wellness is more important to consumers than ever. In the United States alone, we estimate that it represents more than $500 billion in annual spend, growing at four to five per cent each year.' Hilo Band wearable technology for travelers. (Credit: Hilo) As a result of the priority being placed on longevity and preventative health, there has been an explosion of new innovative products and services to meet demand. The Hilo Band (£209.99), for instance, was launched earlier this year to monitor hypertension (or high blood pressure), known as the 'silent killer' and can be worn no matter where you are. Hypertension is the leading cause of heart disease and stroke, affecting millions of people across the UK and globally. As of 2019, approximately 33% of adults worldwide were estimated to have hypertension, with around 46% of those unaware of their condition. The consequences are severe, with hypertension leading to around 10 million deaths worldwide and costing the global economy £260 billion annually. In the UK alone, £2.1 billion is spent annually on hypertension care, with 12% of GP visits related to managing hypertension. The Hilo wrist band and app can be used in conjunction to monitor health. (Credit: Hilo) The Hilo Band is an alternative to traditional blood pressure monitoring methods, which can be innacurate due to factors including poor positioning, incorrect cuff size and low frequency of measurement. Hilo, on the other hand, is non-invasive, and can be worn 24/7 as it has been designed for continual tracking for clinical accuracy. There's also no need to worry about tracking blood pressure manually—the device continually monitors it, offering peace of mind without any extra effort. Taking 20 years of research, Hilo's lightweight wristband passively captures blood pressure readings throughout the day and night, delivering up to 800 measurements per month—all without disrupting the user's daily life. It's ideal to wear when traveling and to give peace of mind when away from home. StrideBiome Kit gives insights into all aspects of health. (Credit: Stride) Meanwhile, another rising focus of wellness is around gut health, with the aforementioned McKinsey report listing the functional nutrition space as one that is booming, with an increased consumer awareness around improving gut microbiome for greater wellbeing. Introducing a new level of technology to the field is Stride, an innovative health optimisation company, which has recenly launched StrideBiome (£279.20) to analyse gut microbiome at home. The easy-to-use test analyses gut health by mapping the micro-organisms that live in your gut. This allows insights into how they impact various aspects of your health and wellbeing. A change in diets, stress and lack of sleep—side-effects of frequent travel—can often be the cause of poor gut health. The test uses 16S rRNA technology to analyse stool samples with extreme accuracy. StrideBiome maps the gut's unique ecosystem to help the user understand their microbiome by analysing over 70 bacterial species across 31 genera and 16 families. The result gives detailed insights into overall gut health, digestive function, gut-brain connection, and metabolic health. The Stride test gives detailed reports unique to each user. (Credit: Stride) After sending off the samples, each user receives a personalised StrideBiome report, delivered within 15 working days (one of the fastest turnarounds on the market due to its cutting-edge, in-house lab based in the UK), along with actionable advice to improve microbiome health and overall health and wellbeing. Users can also make use of a complimentary 1:1 consultation with a dietician team to help dive deeper into areas of interest from the report, discussing any concerns and receiving tailored advice in implementing real, meaningful changes. Importantly, the report reveals how a person's current gut health status affects various aspects of their physical and mental health, such as the strength of the gut-brain axis (how the microbiome communicates with the brain and impacts the ability to cope with things like stress and anxiety); the obesity risk (microbiome can have an impact on the metabolism and therefore there is a risk of putting on weight or the ability to lose weight); digestive health (which links microbiome to specific issues related to how well a person is digesting food); and gut inflammation level (which may impact areas such as the immune response and daily physical health). The DNA test results in a detailed health plan. (Credit: Stride) The launch of StrideBiome follows Stride's first at-home genomics test, StrideDNA (£295.20). This DNA test analyses 110 genes across 9,000 genetic locations to provide over 40 actionable reports and personalised insights into nutrition, fitness, cognitive function, sleep, stress management and skin health. Combining StrideDNA's analysis with StrideBiome's gut testing provides a deeper understanding of the body's needs, especially when travel can cause disruption to health and wellbeing. This dual insight into genetic predispositions and gut bacterial composition allows the company to create tailored nutrition recommendations to optimise each user's health. The Echo Flask is the industry's first smart hydrogen bottle. (Credit: Echo Water) Of course, we all know the importance of hydration, especially when traveling, and Echo Water's new Echo Flask (£299) offers the latest solution, with its cutting-edge hydrogen-enriched water technology. Hydrogen water is a breakthrough therapy offering a powerful solution to reduce oxidative stress, improve cellular health and to take endurance and recovery to a new level Perfect to pack next time you are on the road, Echo Flask, is linked to its companion app, and is the industry's first smart hydrogen bottle, offering the highest hydrogen concentration in combination with the largest water capacity on the market. Combining the latest research with intuitive design, users can generate their own healthy hydrogen water directly in the bottle and use the app to unlock personalized tracking. The Echo Flask brings smart hydration on the go. (Credit: Echo Water) 'Hydrogen has demonstrated powerful health benefits for a huge variety of conditions. With the Echo Flask, we've created a solution that delivers pure hydrogen gas without harmful by-products,' says Paul Barattiero, Ph.D., founder and chief science officer at Echo Water. 'Built on over 2000 studies and thousands of customer testimonials, every element of this product is designed to improve cellular health, reduce oxidative stress, and promote overall wellness.' CALECIM's Advanced Hair System tackles scalp health. (Credit: DON_YEO) Finally, with Vogue Business reporting that 'consumers are increasingly recognising that a healthy scalp underpins hair strength', there has been a rise in demand for problem-solving haircare. CALECIM's Advanced System (£295) uses the latest in hair growth technology and is a science-rich, salon-like treatment, which can be used at-home (or when away) over the course of six weeks. At the heart of the treatment is CALECIM's complex serum, which uses the power of stem cells to replenish follicles and diminish micro-inflammation with unique growth factors, exosomes, cytokines and peptides. The central active ingredient, PTT-6®, regulates a healthy hair cycle, anchoring follicles and creating opportunity for new growth in an unprecedented short time. The serum promotes hair growth. (Credit: Calcium) The system works by stopping micro-inflammation, which disrupts the hair's growth cycle, stopping new growth in its tracks and is easily caused by hormones, stress and genetic disposition. Also containing a multitude of growth factors, these work in tandem to supercharge follicles, with in-vitro testing finding PTT-6® increasing follicle cell production by a staggering 24%. After just four weeks, inflammation is significantly reduced and as such, hair shedding decreases. Both the catagen and telogen phases of the hair cycle (where the hair shaft is released from the scalp) are reduced and, simply put, stay attached to the scalp for longer. This, alongside the abundance of growth factors, normalise the hair cycle, and keep the all-important growth phase running seamlessly. By week six, many users see new growth and an abundance of baby hairs, as well as increased resilience in their hair health. For women, this new growth is typically seen around the hairline and and in men, around the crown. Easy to use and easy to pack, it's hair-raising stuff.
